Skip to main content

Advertisement

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Role of plasma EBV DNA levels in predicting recurrence of nasopharyngeal carcinoma in a western population

  • Daris Ferrari1Email author,
  • Carla Codecà1,
  • Cecilia Bertuzzi1,
  • Francesca Broggio1,
  • Francesca Crepaldi1,
  • Andrea Luciani1,
  • Irene Floriani2,
  • Mohssen Ansarin3,
  • Fausto Chiesa3,
  • Daniela Alterio4 and
  • Paolo Foa1
BMC Cancer201212:208

DOI: 10.1186/1471-2407-12-208

Received: 12 November 2011

Accepted: 16 May 2012

Published: 30 May 2012

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
12 Nov 2011 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
7 Feb 2012 Reviewed Reviewer Report - Jaap M. Middeldorp
10 Feb 2012 Reviewed Reviewer Report - Jin-Ching Lin
Resubmission - Version 3
Submitted Manuscript version 3
30 Mar 2012 Reviewed Reviewer Report - Jaap M. Middeldorp
1 May 2012 Author responded Author comments - Daris Ferrari
Resubmission - Version 4
1 May 2012 Submitted Manuscript version 4
Publishing
16 May 2012 Editorially accepted
30 May 2012 Article published 10.1186/1471-2407-12-208

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Division of Medical Oncology and Department of Medicine, Surgery and Dentistry, San Paolo Hospital and University of Milan
(2)
Istituto di Ricerche Farmacologiche Mario Negri
(3)
Head and Neck Surgery, European Institute of Oncology
(4)
Division of Radiotherapy, European Institute of Oncology, Via Ripamonti

Advertisement